Anti‐inflammatory effects of a titanium‐peroxy gel: Role of oxygen metabolites and apoptosis
Source abstract
Abstract
Abstract Polymorphonuclear neutrophils (PMN) are among the first inflammatory cells to arrive at an implant interface, where they encounter with the foreign material and may produce reactive oxygen species (ROS). During the interaction between titanium and ROS, titanium‐peroxy (Ti‐peroxy) compounds may be formed. We used a Ti‐peroxy gel, made from titanium and hydrogen peroxide, to study the effects of Ti‐peroxy compounds on PMN. In the absence of serum, the Ti‐peroxy gel decreased the oxidative response of PMN to yeast and PMA and reduced PMN apoptosis without inducing necrosis. These effects could not be ascribed to the release of hydrogen peroxide from the Ti‐peroxy gel, because a steady‐state hydrogen peroxide producing system failed to mimic the effects of the gel. The effects were similarly unaffected when PMN were preincubated with β2‐integrin antibodies, questioning the involvement of adhesion molecules. Nevertheless, when a filter was used to separate the Ti‐peroxy gel from the cells, the gel effect on PMN life span was abolished, pointing to a contact‐dependent mechanism. In the presence of serum, the Ti‐peroxy gel had no effect on the PMN oxidative response and life span, but appeared rather inert. In summary, this study demonstrates that the Ti‐peroxy gel has potentially anti‐inflammatory properties through a combined peroxide and physical contact effect, supporting the notion that interactions between titanium and inflammatory cells are responsible for the good performance of titanium in vivo. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 68A: 448–457, 2004
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone and Dental Protein Studies · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. 10.1016/1054-8807(93)90045-410.1016/1054-8807(93)90045-4 ↗
2. 10.1002/jbm.82018091710.1002/jbm.820180917 ↗
3. 10.1016/0142-9612(96)87275-910.1016/0142-9612(96)87275-9 ↗
4. 10.1002/jbm.82026020510.1002/jbm.820260205 ↗
5. 10.1002/jbm.82026080610.1002/jbm.820260806 ↗
6. 10.1067/mlc.2001.11147010.1067/mlc.2001.111470 ↗
7. 10.1172/JCI11324110.1172/JCI113241 ↗
8. 10.1002/(SICI)1097-4636(199601)30:1<67::AID-JBM9>3.0.CO;2-P10.1002/(SICI)1097-4636(199601)30:1<67::AID-JBM9>3.0.CO;2-P ↗
9. 10.1016/S0022-2143(96)90047-510.1016/S0022-2143(96)90047-5 ↗
10. 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O ↗
11. 10.1172/JCI11684110.1172/JCI116841 ↗
12. 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-010.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0 ↗
13. 10.1042/cs083063910.1042/cs0830639 ↗
14. Metal implants and surface reactions
15. 10.1016/0021-9797(89)90117-310.1016/0021-9797(89)90117-3 ↗
16. 10.1002/jbm.82024030510.1002/jbm.820240305 ↗
17. Williams DF · 1981 · 45
18. Isolation of mononuclear cells and granulocytes from human blood
19. 10.1016/S0021-9258(19)52451-610.1016/S0021-9258(19)52451-6 ↗
20. 10.1016/S0014-5793(00)01638-010.1016/S0014-5793(00)01638-0 ↗
21. 10.1016/0003-2697(84)90457-310.1016/0003-2697(84)90457-3 ↗
22. 10.1007/s00011005061610.1007/s000110050616 ↗
23. 10.1096/fasebj.11.13.936735310.1096/fasebj.11.13.9367353 ↗
24. 10.1016/S1074-7613(00)80278-210.1016/S1074-7613(00)80278-2 ↗
25. 10.1083/jcb.151.6.130510.1083/jcb.151.6.1305 ↗
26. Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement10.4049/jimmunol.158.2.945 ↗
27. Clinical observations on the use of titanium salts in the treatment of dermatitis
28. 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O ↗
29. 10.1016/0006-2952(91)90007-R10.1016/0006-2952(91)90007-R ↗
30. 10.1172/JCI10903310.1172/JCI109033 ↗
31. 10.1002/1097-4636(20010605)55:3<257::AID-JBM1013>3.0.CO;2-H10.1002/1097-4636(20010605)55:3<257::AID-JBM1013>3.0.CO;2-H ↗
32. 10.1002/jlb.65.2.19610.1002/jlb.65.2.196 ↗
33. Glow discharge plasma treatment of titanium plates enhances adhesion of osteoblast‐like cells to the plates through the integrin‐mediated mechanism
34. 10.1002/(SICI)1097-4636(19990315)44:4<429::AID-JBM9>3.0.CO;2-C10.1002/(SICI)1097-4636(19990315)44:4<429::AID-JBM9>3.0.CO;2-C ↗
35. 10.1002/1097-4636(200011)52:2<338::AID-JBM13>3.0.CO;2-L10.1002/1097-4636(200011)52:2<338::AID-JBM13>3.0.CO;2-L ↗
36. 10.1016/S0142-9612(01)00290-310.1016/S0142-9612(01)00290-3 ↗
37. 10.1016/S0142-9612(00)00246-510.1016/S0142-9612(00)00246-5 ↗
38. 10.1152/ajpcell.1997.272.1.C29510.1152/ajpcell.1997.272.1.C295 ↗
39. Inhibition of human neutrophil apoptosis by platelets10.4049/jimmunol.158.7.3372 ↗
40. 10.1182/blood.V86.12.4389.bloodjournal8612438910.1182/blood.V86.12.4389.bloodjournal86124389 ↗
41. 10.1083/jcb.125.6.140710.1083/jcb.125.6.1407 ↗